BELYSSE GROUP NV (BELYS.BR) Fundamental Analysis & Valuation

EBR:BELYS • BE0974314461

Current stock price

0.642 EUR
-0.03 (-4.18%)
Last:

This BELYS.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BELYS.BR Profitability Analysis

1.1 Basic Checks

  • In the past year BELYS has reported negative net income.
  • In the past year BELYS had a positive cash flow from operations.
  • In the past 5 years BELYS reported 4 times negative net income.
  • BELYS had a positive operating cash flow in 4 of the past 5 years.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.29%, BELYS is doing worse than 79.41% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -8.98%, BELYS is doing worse than 79.41% of the companies in the same industry.
  • BELYS has a Return On Invested Capital of 7.98%. This is in the better half of the industry: BELYS outperforms 79.41% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BELYS is below the industry average of 9.26%.
  • The 3 year average ROIC (7.23%) for BELYS is below the current ROIC(7.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.29%
ROE -8.98%
ROIC 7.98%
ROA(3y)-0.78%
ROA(5y)-7.99%
ROE(3y)-4.02%
ROE(5y)-43.85%
ROIC(3y)7.23%
ROIC(5y)6.45%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • BELYS has a Operating Margin of 5.81%. This is comparable to the rest of the industry: BELYS outperforms 52.94% of its industry peers.
  • In the last couple of years the Operating Margin of BELYS has declined.
  • BELYS has a better Gross Margin (62.71%) than 88.24% of its industry peers.
  • In the last couple of years the Gross Margin of BELYS has remained more or less at the same level.
Industry RankSector Rank
OM 5.81%
PM (TTM) N/A
GM 62.71%
OM growth 3Y6.01%
OM growth 5Y-6.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y0.62%
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BELYS.BR Health Analysis

2.1 Basic Checks

  • BELYS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for BELYS remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for BELYS is higher compared to a year ago.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • BELYS has an Altman-Z score of 0.66. This is a bad value and indicates that BELYS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.66, BELYS is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
  • BELYS has a debt to FCF ratio of 8.70. This is a slightly negative value and a sign of low solvency as BELYS would need 8.70 years to pay back of all of its debts.
  • The Debt to FCF ratio of BELYS (8.70) is better than 64.71% of its industry peers.
  • BELYS has a Debt/Equity ratio of 1.97. This is a high value indicating a heavy dependency on external financing.
  • BELYS's Debt to Equity ratio of 1.97 is on the low side compared to the rest of the industry. BELYS is outperformed by 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF 8.7
Altman-Z 0.66
ROIC/WACC1.26
WACC6.35%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • BELYS has a Current Ratio of 1.62. This is a normal value and indicates that BELYS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.62, BELYS is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • BELYS has a Quick Ratio of 1.62. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.85, BELYS is in line with its industry, outperforming 55.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.85
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BELYS.BR Growth Analysis

3.1 Past

  • BELYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.68%.
  • The Revenue has grown by 38.68% in the past year. This is a very strong growth!
  • Measured over the past years, BELYS shows a decrease in Revenue. The Revenue has been decreasing by -0.32% on average per year.
EPS 1Y (TTM)-162.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25814.29%
Revenue 1Y (TTM)38.68%
Revenue growth 3Y-9.01%
Revenue growth 5Y-0.32%
Sales Q2Q%87.39%

3.2 Future

  • Based on estimates for the next years, BELYS will show a very strong growth in Earnings Per Share. The EPS will grow by 81.27% on average per year.
  • Based on estimates for the next years, BELYS will show a small growth in Revenue. The Revenue will grow by 2.38% on average per year.
EPS Next Y157.14%
EPS Next 2Y81.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.59%
Revenue Next 2Y2.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

7

4. BELYS.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • BELYS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 3.46 indicates a rather cheap valuation of BELYS.
  • Based on the Price/Forward Earnings ratio, BELYS is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
  • BELYS is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 3.46
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BELYS indicates a rather cheap valuation: BELYS is cheaper than 91.18% of the companies listed in the same industry.
  • 100.00% of the companies in the same industry are more expensive than BELYS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.27
EV/EBITDA 3.5
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • BELYS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BELYS's earnings are expected to grow with 81.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.27%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BELYS.BR Dividend Analysis

5.1 Amount

  • BELYS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BELYS.BR Fundamentals: All Metrics, Ratios and Statistics

BELYSSE GROUP NV

EBR:BELYS (4/16/2026, 7:00:00 PM)

0.642

-0.03 (-4.18%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)03-13
Earnings (Next)04-24
Inst Owners12.64%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap23.07M
Revenue(TTM)388.85M
Net Income(TTM)-6.70M
Analysts84.44
Price Target1.63 (153.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.46
P/S 0.06
P/FCF 1.27
P/OCF 0.77
P/B 0.31
P/tB N/A
EV/EBITDA 3.5
EPS(TTM)-0.18
EYN/A
EPS(NY)0.19
Fwd EY28.88%
FCF(TTM)0.51
FCFY78.79%
OCF(TTM)0.83
OCFY129.39%
SpS10.82
BVpS2.08
TBVpS-0.79
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.29%
ROE -8.98%
ROCE 9.73%
ROIC 7.98%
ROICexc 9.37%
ROICexgc 19.54%
OM 5.81%
PM (TTM) N/A
GM 62.71%
FCFM 4.68%
ROA(3y)-0.78%
ROA(5y)-7.99%
ROE(3y)-4.02%
ROE(5y)-43.85%
ROIC(3y)7.23%
ROIC(5y)6.45%
ROICexc(3y)9.22%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.82%
ROCE(5y)7.87%
ROICexgc growth 3Y5.74%
ROICexgc growth 5Y15.59%
ROICexc growth 3Y2.31%
ROICexc growth 5Y11.32%
OM growth 3Y6.01%
OM growth 5Y-6.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y0.62%
F-Score4
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 1.97
Debt/FCF 8.7
Debt/EBITDA 3.52
Cap/Depr 60.41%
Cap/Sales 3%
Interest Coverage 2.22
Cash Conversion 71.2%
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 0.85
Altman-Z 0.66
F-Score4
WACC6.35%
ROIC/WACC1.26
Cap/Depr(3y)57.26%
Cap/Depr(5y)59.98%
Cap/Sales(3y)4.05%
Cap/Sales(5y)3.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25814.29%
EPS Next Y157.14%
EPS Next 2Y81.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.68%
Revenue growth 3Y-9.01%
Revenue growth 5Y-0.32%
Sales Q2Q%87.39%
Revenue Next Year2.59%
Revenue Next 2Y2.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.12%
EBIT growth 3Y-3.54%
EBIT growth 5Y-6.5%
EBIT Next Year150%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.26%
FCF growth 3Y15.19%
FCF growth 5Y-22.42%
OCF growth 1Y-25.61%
OCF growth 3Y7.85%
OCF growth 5Y-16.92%

BELYSSE GROUP NV / BELYS.BR Fundamental Analysis FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 4 / 10 to BELYS.BR.


Can you provide the valuation status for BELYSSE GROUP NV?

ChartMill assigns a valuation rating of 7 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Undervalued.


What is the profitability of BELYS stock?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for BELYS stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.